Research article · 2019
Conference abstractPublished 24 Apr 2017
Memantine improves cognitive function postoperatively
Arabian Gulf University, Bahrain
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: Persistent impairment in general cognitive functioning postoperatively is reported by clinical studies and is labeled as postoperative cognitive decline (POCD), without specifying which exact cognitive functions are impaired. Animal studies focused on hippocampal injury resulting in memory decline, but also neglected other aspects of cognition. Evidence points to a malignant neuroinflammatory response as the mechanism underlying POCD, with subsequent synaptic impairment and cytokineinduced glutamatergic excitotoxicity. The objective of this study is to evaluate a spectrum of cognitive functions postoperatively, and to investigate the potential effect of memantine, an NMDA-receptor antagonist, on attenuation of POCD. Methodology & Theoretical Orientation: Male mice were divided into memantine (M), and two placebo groups, A and B (PA, PB) (8-10 per group). Memantine was given at a therapeutic dose daily for 30 days prior to the surgery. The memantine and placebo-A groups received isoflurane anesthesia and analgesics, and then underwent a simple laparotomy procedure. The placebo-B group only received anesthesia and analgesia. Neurocognitive testing was then performed on postoperative days (POD) 1 and 7 using the Morris water maze (MWM) to assess memory, the open field test (OFT) for locomotor function and anxiety-like behavior, the tail suspension test (TST) for depression-like behavior, and the three-chamber test (TCT) for sociability and social novelty. Findings: M-POD1 performed significantly better than PA-POD1 on the TCT (p<0.05) and the TST (p<0.001), and showed a tendency to improve on the MWM when compared to PB-POD1. M-POD7 also showed a significant improvement in the TST (p<0.05) and the MWM (p<0.05) when compared to PA-POD7, while TCT showed normal results in both groups. No significant difference was observed between placebo groups and memantine groups on the OFT. Conclusion & Significance: Memantine may improve cognitive functions postoperatively, and could be investigated further as a prophylaxis for POCD.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 2 May 2024
Improve Cognitive Function: Investigating Cognitive Enhancers
Research article · 24 Apr 2020
Use of Virtual Reality Cognitive Training to Improve Executive and Complex Attentional Functions: Can Virtual Reality Performance PredictNeurorehabilitation Outcomes?
Conference abstract · 2019
Evidence-Based practice nursing interventions for improved functional and cognitive outcomes in the Traumatic Brain Injury Patient
Conference abstract · 23 Jul 2018
New-LED-based light therapy improves cognitive function in mouse model of Alzheimer’s disease
More from this journal
The newest in Neurological Disorders.
Commentary · 24 Feb 2026
Vertebrobasilar Dolichoectasia: A Meta-Analysis of Clinical Manifestations and Treatment Approaches
Commentary · 24 Feb 2026
Leveraging Multi-Dimensional Encoding in Single-Channel Haptic Feedback for Enhanced Two-Dimensional Control
Commentary · 24 Feb 2026
The Paradox of Seizure Frequency Reporting: Over counted, Underreported, and Its Clinical Implications
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalNeurological Disorders
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Ahmad I Mahozi”
- BylineArticles whose byline prints “Mohamed Abbas Radhi”
- BylineArticles whose byline prints “Suja Al-Zayer”
- BylineArticles whose byline prints “Amer Kamal”

